Your browser doesn't support javascript.
loading
Primary drug resistance to both rifampicin and dapsone in a paucibacillary leprosy patient.
Indian J Lepr ; 1988 Jan; 60(1): 90-2
Artículo en Inglés | IMSEAR | ID: sea-55423
ABSTRACT
A thirty-one year old male patient was diagnosed and treated for a pure or better primary neuritic case of leprosy with dapsone (100 mg daily for 2 years) and rifampicin (600 mg daily for 6 months). From the very outset, the patient did not show any improvement; on the top of it, he subsequently, developed a cutaneous patch, which on histopathological examination, revealed classical features of BT leprosy. Acid-fast bacilli were absent both in skin slit smear and histologic section. A primary resistance to both dapsone and rifampicin, even in paucibacillary patient, is speculated.
Asunto(s)
Texto completo: Disponible Índice: IMSEAR (Asia Sudoriental) Asunto principal: Rifampin / Humanos / Masculino / Farmacorresistencia Microbiana / Lepra Tuberculoide / Adulto / Dapsona / Quimioterapia Combinada / Mycobacterium leprae Idioma: Inglés Revista: Indian J Lepr Asunto de la revista: Tropical Medicine Año: 1988 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: IMSEAR (Asia Sudoriental) Asunto principal: Rifampin / Humanos / Masculino / Farmacorresistencia Microbiana / Lepra Tuberculoide / Adulto / Dapsona / Quimioterapia Combinada / Mycobacterium leprae Idioma: Inglés Revista: Indian J Lepr Asunto de la revista: Tropical Medicine Año: 1988 Tipo del documento: Artículo